Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.108 (
TAT
)
2,389
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The relationship of hepatic
ornithine decarboxylase
(
ODC
) activity to cyclic AMP levels and nutritional status was studied in the pre-weanling rat. Previous studies demonstrated that 2 hr without food causes a loss of hepatic
ODC
induction after glucagon or catecholamine injection. Isoproterenol or glucagon administration produced increased hepatic cyclic AMP and tyrosine aminotransferase activity which were not prevented by nutritional deprivation. Blockade of hepatic beta 2 receptors by the selective antagonist ICI 118,551 prevented increased cAMP levels and
ODC
activity after isoproterenol administration. Blockade of beta 1 receptors by atenolol did not prevent increased cAMP levels or
ODC
induction by isoproterenol although it did block activation of cardiac
ODC
. The phosphodiesterase inhibitor RO20-1724 increased hepatic cAMP levels as well as
ODC
and
TAT
activities, although the increase in
ODC
activity was attenuated by nutritional deprivation. RO20-1724 also potentiated the induction of hepatic
ODC
after glucagon or isoproterenol administration. Administration of 8-bromo cAMP elevated hepatic
ODC
activity regardless of nutritional status but also elevated serum levels of growth hormone and corticosterone. Hepatic
ODC
induction by glucagon or beta 2 agonists can be dissociated from changes in cAMP levels during nutritional deprivation.
...
PMID:Hepatic cyclic AMP generation and ornithine decarboxylase induction by glucagon and beta adrenergic agonists. 286 May 51
In confluent and serum-starved embryonic heart cell cultures, the addition of serum (10%), glucagon (GLU, 0.1 microM) or isoproterenol (ISO, 10 microM), causes the onset of
ornithine decarboxylase
(
ODC
) activity, with a maximum after 5-6 hr. This is paralleled by polyamine accumulation and by the induction of
TAT
, which, in the case of GLU and ISO, exhibits maximal activity at 4-3 hr respectively, followed by a net decline. Cyclic AMP (cAMP) also accumulates after exposure to GLU or ISO. However, under different conditions of
ODC
inhibition, serum fails to induce
TAT
, thus supporting a relevant role of cellular polyamines in serum action. Conversely, cAMP and
TAT
responses to GLU or ISO are markedly improved under prevention of polyamine accumulation, which also leads to a longer lasting
TAT
inducibility. The suggestion is made that polyamines are not required in the cAMP-dependent mechanism of
TAT
induction, but rather in the restoration of the basal activity of the enzyme.
...
PMID:Study on the role of endogenous polyamines in glucagon, isoproterenol or serum-mediated induction of tyrosine aminotransferase in cultured heart cells. 289 98